推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Molecular Cancer 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

  
学术改写降重工具

 
近期推荐：
热
全流程投稿协助套餐服务
热
SCI论文AI润色+人工QC服务
新
聚合物期刊JPM征稿｜IF持续上升 + APC折扣
热
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Molecular Cancer期刊基本信息Hello，您是该期刊的第240348位访客

基本信息 登录收藏
期刊名字Molecular CancerMolecular Cancer

MOL CANCER
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
8.5
69人评分
我要评分

声誉
8.6

影响力
8.3

速度
8.6

期刊ISSN1476-4598
安装APP，查看期刊最新消息
iOS版下载安装安卓版下载安装
2024-2025最新影响因子
（数据来源于搜索引擎）		33.9 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日：42.26
2024-2025自引率1.8%点击查看自引率趋势图
五年影响因子35.9
JCI期刊引文指标 5.04
h-index 103
CiteScore
（ 2025年最新版）
CiteScoreSJRSNIPCiteScore排名
47.409.2635.233
学科分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Molecular Medicine		Q12 / 177
大类：Biochemistry, Genetics and Molecular Biology
小类：Oncology		Q18 / 415
大类：Biochemistry, Genetics and Molecular Biology
小类：Cancer Research		Q15 / 233

期刊简介
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
期刊官方网站http://molecular-cancer.biomedcentral.com
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理，仅供参考。开通VIP可免费下载，并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载，并享1w+期刊模板资源。
期刊投稿网址https://submission.nature.com/new-submission/12943/3
作者指南网址http://molecular-cancer.biomedcentral.com/submission-guidelines
该期刊中国学者近期发文 - NewSingle-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts (VOL 23,157,2024)
Author: Guo, De-Zhen; Zhang, Xin; Zhang, Sen-Quan; Zhang, Shi-Yu; Zhang, Xiang-Yu; Yan, Jia-Yan; Dong, San-Yuan; Zhu, Kai; Yang, Xin-Rong; Fan, Jia; Zhou, Jian; Huang, Ao
Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02641-6

The multifaceted functions of selective autophagy in cancer: molecular basis, consequences, and clinical prospects
Author: Jiang, Mingyang; Zhang, Ke; Li, Meng; Tian, Yu; Wang, Tao; Rodriguez, Raquel Alarcon; Lin, Zhanghui; Meng, Jinfeng; Li, Chenghao; Wang, Zheng; Wu, Sichang; Cai, Yunfei; Zhang, Wenyang; Guo, Rui; Liu, Yao; Bai, Yuqi; Lai, Guichuan; Zhang, Chengcheng; Bo, Zhandong; Wei, Ruqiong
Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02615-8

KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis
Author: Sun, Rui; Huang, Yong; He, Hao; Li, Qiuchen; Wang, Linfeng; Zhang, Gaojie; Wei, Ziling; Cao, Yang; Li, Jing; Wang, Xianmin; Yang, Fan; Chen, Wenjun; Li, Xiang; Yu, Jiang; Liu, Siyuan; Lei, Congfeng; Jiang, Yu; Peng, Yueqiang; Su, Huiyi; Gao, Yingying; He, Weiyang; Yang, Lei; Liu, Jiayu
Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02602-z

N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma (vol 21, 111, 2022)
Author: Chen, Yuanlei; Lu, Zeyi; Qi, Chao; Yu, Chenhao; Li, Yang; Huan, Wang; Wang, Ruyue; Luo, Wenqin; Shen, Danyang; Ding, Lifeng; Ren, Liangliang; Xie, Haiyun; Xue, Dingwei; Wang, Mingchao; Ni, Kangxin; Xia, Liqun; Qian, Jun; Li, Gonghui
Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02596-8

期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Molecular Cancer的语言要求，还能让Molecular Cancer编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Molecular Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（5篇） 。
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费：需要（ EUR3990; USD4890; GBP3490; ）
文章处理费豁免：查看说明
其他费用：没有
期刊主题关键词：oncology、tumour biology、cancer antigens
相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向医学-生化与分子生物学
出版国家或地区ENGLAND
出版语言English
出版周期Monthly
出版年份2002
年文章数 218点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比：
文章 ÷（文章 + 综述）		56.88%
WOS期刊JCR分区
（ 2024-2025年最新版）		WOS分区等级：1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ14/320
学科：ONCOLOGYSCIEQ19/328
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ13/321
学科：ONCOLOGYSCIEQ111/328
期刊分区表预警名单 2026年03月发布的新锐学术版：不在预警名单中

2025年03月发布的2025版：不在预警名单中

2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
《新锐期刊分区表》
（ 2026年3月发布） 		点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		4区1区1区
ONCOLOGY
肿瘤学		4区4区1区
是N/A
期刊分区表
（ 2025年3月升级版）
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		3区2区1区
ONCOLOGY
肿瘤学		1区4区1区
是否
期刊分区表
（ 2023年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 2区1区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		4区3区1区
ONCOLOGY
肿瘤学		2区2区1区
是否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D
平均审稿速度网友分享经验：
平均2月
平均录用比例网友分享经验：
约50%
版面费/APC文章处理费信息
文章处理费：需要（ EUR3990; USD4890; GBP3490; ）
文章处理费豁免：查看说明
其他费用：没有
LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Molecular Cancer顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（5篇） 。
提交文稿
期刊常用信息链接
同领域相关期刊 Molecular Cancer期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Molecular Cancer期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Molecular Cancer上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE MEDICINE49782.40
    CELL70574.80
    Molecular Plant8528.20
    Annual Review of Biochemistry26828.20
    Molecular Cell35624.40
    CELL DEATH AND DIFFERENTIATION19329.00
    TRENDS IN MICROBIOLOGY17225.80
    PROGRESS IN LIPID RESEARCH13229.90
    TRENDS IN MOLECULAR MEDICINE16021.90
    Nature Chemical Biology18221.50
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE879025
    JOURNAL OF ETHNOPHARMACOLOGY786696
    Frontiers in Immunology720797
    BIOMEDICINE & PHARMACOTHERAPY709936
    BIOMATERIALS702480
    Frontiers in Pharmacology695151
    PHYTOMEDICINE621546
    Frontiers in Oncology605582
    IEEE Journal of Biomedical and Health Informatics577426
    Biomedical Signal Processing and Control576075
  •  

    Molecular Cancer Molecular Cancer
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts (VOL 23,157,2024)

    Author: Guo, De-Zhen; Zhang, Xin; Zhang, Sen-Quan; Zhang, Shi-Yu; Zhang, Xiang-Yu; Yan, Jia-Yan; Dong, San-Yuan; Zhu, Kai; Yang, Xin-Rong; Fan, Jia; Zhou, Jian; Huang, Ao
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02641-6        PubMed      DOI
    2.The multifaceted functions of selective autophagy in cancer: molecular basis, consequences, and clinical prospects

    Author: Jiang, Mingyang; Zhang, Ke; Li, Meng; Tian, Yu; Wang, Tao; Rodriguez, Raquel Alarcon; Lin, Zhanghui; Meng, Jinfeng; Li, Chenghao; Wang, Zheng; Wu, Sichang; Cai, Yunfei; Zhang, Wenyang; Guo, Rui; Liu, Yao; Bai, Yuqi; Lai, Guichuan; Zhang, Chengcheng; Bo, Zhandong; Wei, Ruqiong
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02615-8        PubMed      DOI
    3.KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis

    Author: Sun, Rui; Huang, Yong; He, Hao; Li, Qiuchen; Wang, Linfeng; Zhang, Gaojie; Wei, Ziling; Cao, Yang; Li, Jing; Wang, Xianmin; Yang, Fan; Chen, Wenjun; Li, Xiang; Yu, Jiang; Liu, Siyuan; Lei, Congfeng; Jiang, Yu; Peng, Yueqiang; Su, Huiyi; Gao, Yingying; He, Weiyang; Yang, Lei; Liu, Jiayu
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02602-z        PubMed      DOI
    4.N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma (vol 21, 111, 2022)

    Author: Chen, Yuanlei; Lu, Zeyi; Qi, Chao; Yu, Chenhao; Li, Yang; Huan, Wang; Wang, Ruyue; Luo, Wenqin; Shen, Danyang; Ding, Lifeng; Ren, Liangliang; Xie, Haiyun; Xue, Dingwei; Wang, Mingchao; Ni, Kangxin; Xia, Liqun; Qian, Jun; Li, Gonghui
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02596-8        PubMed      DOI
    5.CircEAF2 counteracts Epstein-Barr viruspositive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis (vol 20, 153, 2021)

    Author: Zhao, Chen-xing; Yan, Zi-xun; Wen, Jing-jing; Fu, Di; Xu, Peng-peng; Wang, Li; Cheng, Shu; Hu, Jian-da; Zhao, Wei-li
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02592-y        PubMed      DOI
    6.Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression

    Author: Zhou, Yumei; Bai, Minghua; Chen, Longjiao; Han, Hui; Hou, Shujuan; Wang, Xiaolu; Fan, Pengbei; Han, Shuai; Chen, Fangfang; Li, Jian; Wang, Ji; Wang, Qi
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02583-z        PubMed      DOI
    7.Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy

    Author: Wang, Zhenyu; Wang, Zikang; Jiang, Jiyue; Yang, Lu; Li, Chunxiao; Deng, Xiuwen; Li, Yu; Yuan, Jiao; Jiang, Ping; Wang, Junjie
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02600-1        PubMed      DOI
    8.Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs

    Author: Jian, Chengli; Fu, Hao; Wu, Wantao; Zhang, Nan; Liu, Zaoqu; Xia, Zhiwei; Luo, Peng; Zhang, Hao; Cheng, Quan
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02594-w        PubMed      DOI
    9.The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC (vol 20, 91, 2021)

    Author: Wang, Xiaosong; Xing, Lei; Yang, Rui; Chen, Hang; Wang, Min; Jiang, Rong; Zhang, Luyu; Chen, Junxia
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02584-y        PubMed      DOI
    10.MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma (vol. 12, 123, 2013)

    Author: Liu, Na; Jiang, Ning; Guo, Rui; Jiang, Wei; He, Qing-Mei; Xu, Ya-Fei; Li, Ying-Qin; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Ma, Jun
    Journal: MOLECULAR CANCER. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s12943-026-02595-9        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    ANNALS OF ONCOLOGY21070.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS MICROBIOLOGY250106.40
    NATURE REVIEWS DRUG DISCOVERY289181.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386150.90
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Materials61105.50
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    Nature Reviews Earth & Environment070.00
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：
投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板，让您的学术沟通高效得体，显著提升论文发表效率！开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验：共1017条

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）

    增值电信业务经营许可证：沪B2-20211595    网络文化经营许可证：沪网文[2023]2004-152号

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室